Anew Medical Inc ký thỏa thuận sáp nhập với Redwoods Acquisition Corp.

Anew Medical, Inc. has recently signed a definitive merger agreement with Redwoods Acquisition Corp, a business proposal worth approximately $94 million. The acquisition will result in Anew Medical operating as a new drug and continuing to be listed on NASDAQ after the closing of the deal. Redwoods will provide around $54 million in cash to finance the acquisition, with no changes to shareholders’ equity. This business move is expected to bring significant benefits to both companies and is a strategic step towards growth and development. Stay tuned for more updates on this exciting merger.